Haemonetics (HAE) Assets Average (2010 - 2026)

Haemonetics has reported Assets Average for 17 years, with the latest figure at $2.4 billion in Q2 2026.

• On a quarterly basis, Assets Average fell 3.09% year-over-year to $2.4 billion in Q2 2026; TTM through Jun 2026 was $2.4 billion, a 3.09% decrease from a year earlier, with the FY2026 full-year figure at $2.4 billion, up 4.31% from the prior year.
• Assets Average was $2.4 billion for Q2 2026 at Haemonetics, down from $2.4 billion in the prior quarter.
• The five-year high for Assets Average was $2.5 billion in Q3 2024, with the low at $1.8 billion in Q1 2022.
• Average Assets Average over 5 years is $2.2 billion, with a median of $2.2 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Assets Average jumped 32.77% in 2022, then declined 3.2% in 2025.
• Over 5 years, Assets Average stood at $1.9 billion in 2022, then advanced by 12.52% to $2.1 billion in 2023, then rose by 20.06% to $2.5 billion in 2024, then fell by 2.44% to $2.5 billion in 2025, then declined by 3.48% to $2.4 billion in 2026.
• The last three Assets Average figures came in at $2.4 billion (Q2 2026), $2.4 billion (Q1 2026), and $2.5 billion (Q4 2025), per Business Quant data.